Author
@_inpractise
grade Bx.com/_inpractise ↗
In Practise is explicitly built for long-term fundamental equity investors, publishing executive interviews, investment research, company profiles, and value-chain analysis, so its
trader score
+0.87
hit rate
45%
mean α
+0.46%
signals 14d
16
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Across their last 20 scored bets: 45% hit rate, +0.46% mean alpha, trader score +0.87. Their last-14d mentions, direction-adjusted, have moved +8.4% since posting (mean over 9 mentions with price data).
Recent signals15receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-06-24 | DIE | @_inpractise | +0.40 | Former VP says rivals cannot build a national #2 to Safelite. | · | tweet ↗ |
| 2026-06-24 | WDAY | @_inpractise | +0.45 | Former product architect discusses moat protecting Workday from entrants. | +14.7% | tweet ↗ |
| 2026-06-24 | CPNG | @_inpractise | +0.45 | Former Coupang head says WOW delivery footprint cannot be copied. | +4.5% | tweet ↗ |
| 2026-06-24 | ALC | @_inpractise | +0.35 | Former Carl Zeiss product head discusses clinic lock-in from consigned-lens bundles. | · | tweet ↗ |
| 2026-06-24 | VEEV | @_inpractise | +0.45 | Former Novartis commercial lead says leaving Veeva is difficult. | +19.5% | tweet ↗ |
| 2026-06-23 | MIPS | @_inpractise | +0.35 | Former product head says MIPS sells brand/signal, not just tech. | · | tweet ↗ |
| 2026-06-23 | SECT | @_inpractise | +0.40 | Health IT director says ripping out SECT is hard. | · | tweet ↗ |
| 2026-06-23 | UTZ | @_inpractise | +0.25 | Route owner says each $1 of weekly sales is worth $20 in route sale value. | · | tweet ↗ |
| 2026-06-23 | APPF | @_inpractise | +0.25 | Customer criticizes AI but says he still will not cancel APPF. | · | tweet ↗ |
| 2026-06-23 | WISE | @_inpractise | +0.45 | Former Wise KYC head says new cross-border entrants fail within 18 months. | -3.4% | tweet ↗ |
| 2026-06-21 | ZETA | @_inpractise | +0.45 | Customer quote implies high switching costs and retention for ZETA. | +9.5% | tweet ↗ |
| 2026-06-21 | BSX | @_inpractise | +0.45 | Urologist explains willingness to pay 4-5x more for BSX LithoVue. | -0.3% | tweet ↗ |
| 2026-06-20 | LEN | @_inpractise | +0.30 | Former division president cites Lennar scale buying trades with 2-3k homes. | -1.7% | tweet ↗ |
| 2026-06-20 | GE | @_inpractise | +0.35 | Former CFM director explains warranty moat keeping PMA parts out of GE engines. | +5.6% | tweet ↗ |
| 2026-06-19 | KVYO | @_inpractise | +0.40 | Customer quote implies KVYO is easy to join and hard to leave. | +27.5% | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.